Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3035)
All Articles published online
|
May 28, 2009 (publication date) through Jul 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vilas-Boas WW, Ribeiro-Oliveira Jr A, Pereira RM, Ribeiro RDC, Almeida J, Nadu AP, Simões e Silva AC, Santos RASD. Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis. World J Gastroenterol 2009; 15(20): 2512-2519 [PMID: 19469002 DOI: 10.3748/wjg.15.2512] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i20/2512.htm |
| Number | Citing Articles |
| 1 |
Yannis Dimitroglou, Constantina Aggeli, Alexandra Alexopoulou, Sophie Mavrogeni, Dimitris Tousoulis. Cardiac Imaging in Liver Transplantation Candidates: Current Knowledge and Future Perspectives. Journal of Clinical Medicine 2019; 8(12): 2132 doi: 10.3390/jcm8122132
|
| 2 |
Robson Augusto Souza Santos, Walkyria Oliveira Sampaio, Andreia C. Alzamora, Daisy Motta-Santos, Natalia Alenina, Michael Bader, Maria Jose Campagnole-Santos. The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7). Physiological Reviews 2018; 98(1): 505 doi: 10.1152/physrev.00023.2016
|
| 3 |
Mary S. McGrath, Brian J. Wentworth. The Renin–Angiotensin System in Liver Disease. International Journal of Molecular Sciences 2024; 25(11): 5807 doi: 10.3390/ijms25115807
|
| 4 |
Puneeta Tandon, Juan G. Abraldes, Annalisa Berzigotti, Juan Carlos Garcia-Pagan, Jaime Bosch. Renin–angiotensin–aldosterone inhibitors in the reduction of portal pressure: A systematic review and meta-analysis. Journal of Hepatology 2010; 53(2): 273 doi: 10.1016/j.jhep.2010.03.013
|
| 5 |
Ana Cristina Simões e Silva, Aline S Miranda, Natália P Rocha, Antônio L Teixeira. Renin angiotensin system in liver diseases: Friend or foe?. World Journal of Gastroenterology 2017; 23(19): 3396-3406 doi: 10.3748/wjg.v23.i19.3396
|
| 6 |
Ana Cristina Simões e Silva, Katharina Lanza, Vitória Andrade Palmeira, Larissa Braga Costa, Joseph T. Flynn. 2020 update on the renin–angiotensin–aldosterone system in pediatric kidney disease and its interactions with coronavirus. Pediatric Nephrology 2021; 36(6): 1407 doi: 10.1007/s00467-020-04759-1
|
| 7 |
Shu Li, Qinglan Wang, Yanyan Tao, Chenghai Liu. Swertiamarin Attenuates Experimental Rat Hepatic Fibrosis by Suppressing Angiotensin II–Angiotensin Type 1 Receptor–Extracellular Signal-Regulated Kinase Signaling. Journal of Pharmacology and Experimental Therapeutics 2016; 359(2): 247 doi: 10.1124/jpet.116.234179
|
| 8 |
Roberto Monreal-Robles, Carlos A. Cortez-Hernández, José A. González-González, Juan G. Abraldes, Francisco J. Bosques-Padilla, Héctor N. Silva-Ramos, Jorge A. García-Flores, Héctor J. Maldonado-Garza. Acute Variceal Bleeding: Does Octreotide Improve Outcomes in Patients with Different Functional Hepatic Reserve?. Annals of Hepatology 2018; 17(1): 125 doi: 10.5604/01.3001.0010.7544
|
| 9 |
Josephine A. Grace, Chandana B. Herath, Kai Yan Mak, Louise M. Burrell, Peter W. Angus. Update on new aspects of the renin–angiotensin system in liver disease: clinical implications and new therapeutic options. Clinical Science 2012; 123(4): 225 doi: 10.1042/CS20120030
|
| 10 |
Hsin-Ling Ho, Hui-Chun Huang. Molecular mechanisms of circulatory dysfunction in cirrhotic portal hypertension. Journal of the Chinese Medical Association 2015; 78(4): 195 doi: 10.1016/j.jcma.2014.10.004
|
| 11 |
Ana Cristina Simões Silva, Sérgio Veloso Brant Pinheiro. The Protective Arm of the Renin Angiotensin System (RAS). 2015; : 207 doi: 10.1016/B978-0-12-801364-9.00029-8
|
| 12 |
Ghulam Abbas, Marina G Silveira, Keith D Lindor. Hepatic Fibrosis and the Renin-Angiotensin System. American Journal of Therapeutics 2011; 18(6): e202 doi: 10.1097/MJT.0b013e3181df8df5
|
| 13 |
Clare A. McKinney, Caroline Fattah, Christopher M. Loughrey, Graeme Milligan, Stuart A. Nicklin. Angiotensin-(1–7) and angiotensin-(1–9): function in cardiac and vascular remodelling. Clinical Science 2014; 126(12): 815 doi: 10.1042/CS20130436
|
| 14 |
Aline Silva de Miranda, Ana Cristina Simões e Silva. Angiotensin-(1-7). 2019; : 191 doi: 10.1007/978-3-030-22696-1_12
|
| 15 |
Marco Antonio López Hernández. Management of Chronic Liver Diseases - Recent Advances. 2018; doi: 10.5772/intechopen.78571
|
| 16 |
AC Simões e Silva, KD Silveira, AJ Ferreira, MM Teixeira. ACE2, angiotensin‐(1‐7) and Mas receptor axis in inflammation and fibrosis. British Journal of Pharmacology 2013; 169(3): 477 doi: 10.1111/bph.12159
|
| 17 |
Qianqian Zhu, Na Li, Fang Li, Zhihua Zhou, Qunying Han, Yi Lv, Jiao Sang, Zhengwen Liu. Therapeutic effect of renin angiotensin system inhibitors on liver fibrosis. Journal of the Renin-Angiotensin-Aldosterone System 2016; 17(1): 147032031662871 doi: 10.1177/1470320316628717
|
| 18 |
Lakmie S. Gunarathne, Indu G. Rajapaksha, Stephen Casey, Tawar Qaradakhi, Anthony Zulli, Harinda Rajapaksha, Jonel Trebicka, Peter W. Angus, Chandana B. Herath. Mas‐related G protein‐coupled receptor type D antagonism improves portal hypertension in cirrhotic rats. Hepatology Communications 2022; 6(9): 2523 doi: 10.1002/hep4.1987
|
| 19 |
Yannis Dimitroglou, Constantina Aggeli, Alexandra Alexopoulou, Dimitrios Tsartsalis, Dimitrios Patsourakos, Markos Koukos, Dimitris Tousoulis, Konstantinos Tsioufis. The Contemporary Role of Speckle Tracking Echocardiography in Cirrhotic Cardiomyopathy. Life 2024; 14(2): 179 doi: 10.3390/life14020179
|
| 20 |
Josephine A. Grace, Sabine Klein, Chandana B. Herath, Michaela Granzow, Robert Schierwagen, Noemi Masing, Thomas Walther, Tilman Sauerbruch, Louise M. Burrell, Peter W. Angus, Jonel Trebicka. Activation of the Mas Receptor by Angiotensin-(1–7) in the Renin–Angiotensin System Mediates Mesenteric Vasodilatation in Cirrhosis. Gastroenterology 2013; 145(4): 874 doi: 10.1053/j.gastro.2013.06.036
|
| 21 |
Fiona J. Warner, Harinda Rajapaksha, Nicholas Shackel, Chandana B. Herath. ACE2: from protection of liver disease to propagation of COVID-19. Clinical Science 2020; 134(23): 3137 doi: 10.1042/CS20201268
|
| 22 |
Lakmie S Gunarathne, Harinda Rajapaksha, Nicholas Shackel, Peter W Angus, Chandana B Herath. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics. World Journal of Gastroenterology 2020; 26(40): 6111-6140 doi: 10.3748/wjg.v26.i40.6111
|
| 23 |
Csaba Matyas, György Haskó, Lucas Liaudet, Eszter Trojnar, Pal Pacher. Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications. Nature Reviews Cardiology 2021; 18(2): 117 doi: 10.1038/s41569-020-0433-5
|
| 24 |
M Kamruzzman Munshi, Mohammad N Uddin, Shannon S Glaser. The role of the renin–angiotensin system in liver fibrosis. Experimental Biology and Medicine 2011; 236(5): 557 doi: 10.1258/ebm.2011.010375
|
| 25 |
Lakmie S. Gunarathne, Peter W. Angus, Chandana B. Herath. Blockade of Mas Receptor or Mas-Related G-Protein Coupled Receptor Type D Reduces Portal Pressure in Cirrhotic but Not in Non-cirrhotic Portal Hypertensive Rats. Frontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.01169
|
| 26 |
Arnaldo Schainberg, Antônio Ribeiro-Oliveira Jr., José Marcio Ribeiro. Is there a link between glucose levels and heart failure? An update. Arquivos Brasileiros de Endocrinologia & Metabologia 2010; 54(5): 488 doi: 10.1590/S0004-27302010000500010
|
| 27 |
Stephen Casey, Robert Schierwagen, Kai Yan Mak, Sabine Klein, Frank Uschner, Christian Jansen, Michael Praktiknjo, Carsten Meyer, Daniel Thomas, Chandana Herath, Robert Jones, Jonel Trebicka, Peter Angus. Activation of the Alternate Renin-Angiotensin System Correlates with the Clinical Status in Human Cirrhosis and Corrects Post Liver Transplantation. Journal of Clinical Medicine 2019; 8(4): 419 doi: 10.3390/jcm8040419
|
| 28 |
Indu G. Rajapaksha, Lakmie S. Gunarathne, Peter W. Angus, Chandana B. Herath. Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options. Journal of Clinical Medicine 2021; 10(4): 702 doi: 10.3390/jcm10040702
|
| 29 |
Amal M. Mahfoz, Aya Y. Gawish. Insight into the hepatoprotective, hypolipidemic, and antidiabetic impacts of aliskiren in streptozotocin-induced diabetic liver disease in mice. Diabetology & Metabolic Syndrome 2022; 14(1) doi: 10.1186/s13098-022-00935-5
|
| 30 |
Ana Cristina Simões e Silva, Robson Augusto Souza Santos. Angiotensin-(1-7). 2019; : 117 doi: 10.1007/978-3-030-22696-1_8
|
| 31 |
Priscila Menezes Ferri Liu, Sarah Tayná de Carvalho, Pollyanna Faria Fradico, Maria Luiza Barreto Cazumbá, Ramon Gustavo Bernardino Campos, Ana Cristina Simões e Silva. Hepatorenal syndrome in children: a review. Pediatric Nephrology 2021; 36(8): 2203 doi: 10.1007/s00467-020-04762-6
|
| 32 |
Eun Hui Bae, Ana Konvalinka, Fei Fang, Xiaohua Zhou, Vanessa Williams, Nicholas Maksimowski, Xuewen Song, Shao-Ling Zhang, Rohan John, Gavin Y. Oudit, York Pei, James W. Scholey. Characterization of the Intrarenal Renin-Angiotensin System in Experimental Alport Syndrome. The American Journal of Pathology 2015; 185(5): 1423 doi: 10.1016/j.ajpath.2015.01.021
|